103 related articles for article (PubMed ID: 3260709)
1. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
Szabó B; Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
Acta Microbiol Hung; 1986; 33(2):103-10. PubMed ID: 3492851
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction.
Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
Acta Microbiol Hung; 1984; 31(4):365-72. PubMed ID: 6085606
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. I. Blocking activity of gp70 antigens of primate type C viruses.
Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
Neoplasma; 1983; 30(2):129-35. PubMed ID: 6302527
[TBL] [Abstract][Full Text] [Related]
5. Studies on the specificity of human antibodies reacting with GP70 and P15 antigens of baboon endogenous (BaEV) and gibbon ape leukaemia (GaLV) viruses.
Tóth FD; Váczi L; Szabó B; Réthy A; Rák K; Kiss J; Kiss A
Acta Virol; 1984 May; 28(3):191-7. PubMed ID: 6147994
[TBL] [Abstract][Full Text] [Related]
6. Studies on antigens of C-type primate viruses and antibodies to them at patients with myeloid leukemia and potentially preleukemic hematological disorders.
Váczi L; Tóth FD
Arch Geschwulstforsch; 1980; 50(8):769-77. PubMed ID: 6261716
[TBL] [Abstract][Full Text] [Related]
7. Studies on antibodies reactive with glycoproteins of primate type C viruses in patients with myeloid leukemias and with potential preleukemia.
Tóth FD; Váczi L; Réthy A; Szabó B; Kiss J; Kiss A; Rák K
Neoplasma; 1982; 29(4):397-401. PubMed ID: 6290914
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
[TBL] [Abstract][Full Text] [Related]
9. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
10. Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission.
Torelli GF; Guarini A; Palmieri G; Breccia M; Vitale A; Santoni A; Foa R
Br J Haematol; 2002 Feb; 116(2):299-307. PubMed ID: 11841430
[TBL] [Abstract][Full Text] [Related]
11. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
[TBL] [Abstract][Full Text] [Related]
12. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
Pullen S; Hersey P
Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
[TBL] [Abstract][Full Text] [Related]
13. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
15. Specific antibodies to viruses HL-23 and BILN in the blood plasma of patients with acute myelogenous leukaemia and with potential preleukaemia.
Tóth FD; Kiss J; Váczi L; Madár Z; Jakó J; Rák K
Acta Microbiol Acad Sci Hung; 1980; 27(2):147-53. PubMed ID: 6251702
[TBL] [Abstract][Full Text] [Related]
16. Detection by radioimmunoassay of antigens related to the P30 polypeptides of primate type C oncoviruses in peripheral leukocytes from patients with chronic myelogenous leukaemia.
Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
Acta Virol; 1981 Nov; 25(6):376-80. PubMed ID: 6120639
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.
Taylor GM; Fergusson WD; Harris R
Clin Exp Immunol; 1979 Jan; 35(1):53-61. PubMed ID: 154982
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral immune response and plasma interferon in different phases of chronic granulocytic leukemia.
Szabó B; Tóth FD; Kiss J; Kiss A; Rák K
Leuk Res; 1993 Apr; 17(4):311-23. PubMed ID: 7683737
[TBL] [Abstract][Full Text] [Related]
19. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
20. [Foetal antigens on leukaemia cells (author's transl)].
Thränhardt H; Zintl F; Milleck J; Plenert W
Arch Geschwulstforsch; 1978; 48(8):750-5. PubMed ID: 288321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
